Announced Fri, 10 Jul · 19:43 IST
Dhanuka Labs amalgamates into Orchid Pharma; share ratio and record date set
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.9%1-day move
₹1008.45
prior close
₹1009.05
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.8-0.0+0.0+4.9+9.2+6.8+2.9+3.8-0.8————
Up moveDown movePending
AI summary
Dhanuka Laboratories is being merged into Orchid Pharma, with the scheme made effective July 10, 2026 and appointed date April 1, 2024. DLL stands dissolved without winding up. Exchange ratio: 161 OPL equity shares of Rs.10 face value for every 5 DLL equity shares of Rs.100 face value. Record date for eligible DLL shareholders is July 23, 2026. Orchid Pharma authorized capital rises to Rs.164.51 crore, divided into 16.45 crore equity shares of Rs.10 each.
Likely market impact
DLL shareholders get 161 OPL shares per 5 DLL shares held; OPL absorbs DLL assets and liabilities, expanding its capital base and share count.